Stockreport

Windtree Therapeutics reports Q2 results [Seeking Alpha]

Windtree Therapeutics, Inc.  (WINT) 
Last windtree therapeutics, inc. earnings: 8/21 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: windtreetx.investorroom.com
PDF Windtree Therapeutics (NASDAQ: WINT ): Q2 EPS of -$0.76 Revenue of $1.15M (+1050.0% Y/Y) Press Release Now read: Retrophin: Updates To Thesis » [Read more]